Blaustein Marc - Insider Non-Derivative Transactions at Finch Therapeutics Group, Inc. (FNCH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 21, 2023, Blaustein Marc's relationship to Finch Therapeutics Group, Inc. (FNCH) is Officer (Chief Operating Officer), and currently has 27,995 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FNCH insiders.
Data Source: SEC.
Blaustein Marc - Insider Non-Derivative Transactions at FNCH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 22, 2023 | Sell -- (Common Stock) | 4619 | 0.38 | 27995 |